Food and Drug Administration Perspective
2006; Lippincott Williams & Wilkins; Volume: 114; Issue: 12 Linguagem: Inglês
10.1161/circulationaha.106.647800
ISSN1524-4539
AutoresOwen Faris, Mitchell J. Shein,
Tópico(s)Cardiac Imaging and Diagnostics
ResumoHomeCirculationVol. 114, No. 12Food and Drug Administration Perspective Free AccessEditorialPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessEditorialPDF/EPUBFood and Drug Administration PerspectiveMagnetic Resonance Imaging of Pacemaker and Implantable Cardioverter-Defibrillator Patients Owen P. Faris, PhD and Mitchell Shein, MS Owen P. FarisOwen P. Faris From the Division of Cardiovascular Devices, Center for Devices and Radiological Health, Food and Drug Administration, Rockville, Md. and Mitchell SheinMitchell Shein From the Division of Cardiovascular Devices, Center for Devices and Radiological Health, Food and Drug Administration, Rockville, Md. Originally published19 Sep 2006https://doi.org/10.1161/CIRCULATIONAHA.106.647800Circulation. 2006;114:1232–1233In April 2005, the US Food and Drug Administration (FDA) commented on the current research regarding the use of magnetic resonance imaging (MRI) on patients with a pacemaker or implantable cardioverter-defibrillator (ICD).1 Pacemaker and ICD labeling currently cautions physicians against the use of MRI, and MRI manufacturers contraindicate MRI for pacemaker and ICD patients. As discussed in our previous editorial, several studies have demonstrated the potential for MRI to be performed in pacemaker or ICD patients without serious clinical consequence.2–4 Studies presented by Sommer et al5 and Nazarian et al6 in this issue of Circulation offer further promising evidence in this regard. As with the previous studies, however, the authors acknowledge a multitude of limitations that prevent broad applicability of the results. Furthermore, one of these studies was not entirely free from concerning outcomes with the potential for serious clinical events. We view these results as consistent with our previous message that, on a case-by-case basis, the diagnostic benefit from MRI outweighs the presumed risks for some pacemaker and ICD patients. However, the FDA remains firm in its belief that those risks have not yet been characterized and mitigated sufficiently to justify the routine use of MRI in those populations. The FDA continues to believe that a more thorough evaluation of concerns related to heating, arrhythmogenesis, and proper device function during and after MRI, as well as validated MR protocols, should be available before approval for labeling that endorses the use of MRI for pacemaker or ICD patients is obtained.Articles pp 1277 and 1285The studies presented by Sommer et al5 and Nazarian et al6 in this issue involved a total of 113 pacemaker and 24 ICD patients who underwent 183 MR exams for an urgent or MR-specific clinical need. The Sommer et al study was limited to patients with a pacemaker from a single manufacturer; the Nazarian et al study enrolled only patients whose pacemaker or ICD model had already been evaluated through in vitro and in vivo testing by the authors. Each study was restricted to a single MR system manufacturer and model. Meaningful exclusion criteria included pacemaker dependency and the need for a thoracic MR scan for the Sommer et al study and the presence of an epicardial, nonfixated, or abandoned lead for the Nazarian et al study. It is important to note that the MR scanning parameters allowed for clinically relevant scans that were moderately rigorous in terms of specific absorption rate. Both studies demonstrated the encouraging result of no observed adverse clinical events. Furthermore, Nazarian et al comment that the MR examination resulted in a clinical diagnosis in nearly all subjects.Although the ability to arrive at clinical diagnoses is a positive note, other outcomes, particularly from the Sommer et al study, have implications that are of concern. Seven of the 115 MR exams in the Sommer et al study resulted in pacemaker reset and a reversion to the factory VVI settings, and in 21 of the 47 devices evaluated, the reed switch did not close to activate the magnet mode for the device. Although not exhibited in this study, these 2 malfunctions in combination could have serious consequences, particularly for a pacemaker-dependent patient, because MR-induced interference could be sensed by the pacemaker, resulting in inhibition of therapy. This observation is consistent with other studies that have demonstrated that MRI may adversely affect the function or programmability of certain ICDs or pacemakers.7 To date, published studies have not thoroughly explored the extent to which the risk for device malfunction is dependent on scan parameters, MR system, and patient and device position within the MR system or the device design.Results of the Sommer et al5 study also indicate the presence of tissue damage as assessed by small but statistically significant changes in mean pacing threshold and lead impedance across patients, and clinically meaningful changes in pacing threshold and troponin I for some individual patients. The Nazarian et al6 study did not demonstrate any statistically significant changes in the means for sensing amplitude, lead impedance, or pacing threshold. Of note, Nazarian et al did not present data regarding individual patient outcomes. The Sommer et al results are consistent with previous studies that indicate that the potential for MR-induced thermal injury in pacemaker and ICD patients exists and that methods for consistently avoiding such heating have not been validated.8 In the study conducted by Martin et al,3 for example, 9.4% of the leads studied exhibited a "significant" change in pacing threshold; most of these changes were threshold increases, likely indicating thermal injury. Of particular concern is the potential cumulative effect for patients who undergo several MRI procedures.It is encouraging to note that neither study presented in this issue reports observed arrhythmia induction from MRI. However, as acknowledged by Sommer et al,5 the potential for such events exists. This is consistent with the FDA's perspective that, although arrhythmia induction in pacemaker or ICD patients from MRI is likely a rare event, the consequences could be catastrophic. This is of particular concern for ICD patients who may be more susceptible to arrhythmias and would likely have their ICD disabled during the MRI procedure. Both studies presented in this issue followed rigorous patient monitoring protocols to avoid such an event. However, the FDA remains concerned that the extent to which arrhythmogenic risk is dependent on scan parameters, MR system, patient and device position, and device design has not been adequately characterized. Furthermore, protocols such as those presented in this issue, while worthy of consideration, have not been sufficiently validated to support routine clinical use.Given the range of available MR systems and scan conditions, pacemaker and ICD systems and leads, and the range of potential patient conditions, the authors of both studies presented in this issue acknowledge the limitations that prevent extending these encouraging results to recommendations for routine use of MRI in pacemaker and ICD patients. Of note, given the potential risks that an MR procedure presents, both studies were limited to patients with a substantial clinical need for MRI. The FDA concurs with the authors that, for some patients, the risks presented by MRI under specific, characterized scanning and monitoring conditions may be acceptable given the diagnostic benefit of this powerful imaging modality.The FDA continues to believe that extending MRI use to the general pacemaker and ICD patient population through removal or modification of device warnings and contraindications will require thorough characterization of the array of safety concerns related to heating, arrhythmogenesis, and proper device function and validation of the measures taken to mitigate these concerns. Although many of these concerns are best addressed through bench and animal studies, prospectively designed and adequately powered clinical trials will likely be necessary to confirm the results from preclinical testing. The FDA is committed to working with pacemaker and ICD manufacturers to pursue these studies to seek labeling modifications for their devices.The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.The views and opinions expressed are those of the authors and do not necessarily reflect those of the US Food and Drug Administration or the US Department of Health and Human Services.DisclosuresNone.FootnotesCorrespondence to Mitchell J. Shein, MS, FDA Expert, Cardiac Pacing, Division of Cardiovascular Devices, Center for Devices and Radiological Health, Food and Drug Administration, 9200 Corporate Boulevard, Rockville, MD 20850. E-mail [email protected] References 1 Faris OP, Shein MJ. Government viewpoint: US Food and Drug Administration: pacemakers, ICDs, and MRI. Pacing Clin Electrophysiol. 2005; 28: 268–269.CrossrefMedlineGoogle Scholar2 Gimbel JR, Kanal E, Schwartz KM, Wilkoff BL. Outcome of magnetic resonance imaging (MRI) in selected patients with implantable cardioverter defibrillators (ICDs). Pacing Clin Electrophysiol. 2005; 28: 268–269.CrossrefMedlineGoogle Scholar3 Martin ET, Coman JA, Shellock FG, Pulling CC, Fair R, Jenkins K. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol. 2004; 43: 1315–1324.CrossrefMedlineGoogle Scholar4 Roguin A, Zviman MM, Meininger GR, Rodrigues ER, Dickfeld TM, Bluemke DA, Lardo A, Berger RD, Calkins H, Halperin HR. Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe in vitro and in vivo assessment of safety and function at 1.5 T. Circulation. 2004; 110: 475–482.LinkGoogle Scholar5 Sommer T, Naehle CP, Yang A, Zeijlemaker V, Hackenbroch M, Schmiedel A, Meyer C, Strach K, Skowasch D, Vahlhaus C, Litt H, Schild H. Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 T in the presence of cardiac pacemakers in non–pacemaker-dependent patients: a prospective study with 115 examinations. Circulation. 2006; 114: 1285–1292.LinkGoogle Scholar6 Nazarian S, Roguin A, Zviman MM, Lardo AC, Dickfeld TL, Calkins H, Weiss RG, Berger RD, Bluemke DA, Halperin HR. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable cardioverter-defibrillators at 1.5 Tesla. Circulation. 2006; 114: 1277–1284.LinkGoogle Scholar7 Fiek M, Remp T, Reithmann C, Steinbeck G. Complete loss of ICD programmability after magnetic resonance imaging. Pacing Clin Electrophysiol. 2004; 27: 1002–1004.CrossrefMedlineGoogle Scholar8 Sommer T, Vahlhaus C, Lauck G, von Smekal A, Reinke M, Hofer U, Block W, Traber F, Schneider C, Gieseke J, Jung W, Schild H. MR imaging and cardiac pacemakers: in vitro evaluation and in vivo studies in 51 patients at 0.5 T. Radiology. 2000; 215: 869–879.CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By König C, Tinhofer F, Puntus T, Burger A, Neubauer N, Langenberger H, Huber K, Nürnberg M and Zweiker D (2021) Is diversity harmful?—Mixed-brand cardiac implantable electronic devices undergoing magnetic resonance imaging, Wiener klinische Wochenschrift, 10.1007/s00508-021-01924-w, 134:7-8, (286-293), Online publication date: 1-Apr-2022. Arduino A, Bottauscio O, Chiampi M, Zanovello U and Zilberti L (2022) A contribution to MRI safety testing related to gradient‐induced heating of medical devices , Magnetic Resonance in Medicine, 10.1002/mrm.29235, 88:2, (930-944), Online publication date: 1-Aug-2022. Mangini F, Samar H, Gevenosky L, Williams R, Shah M, Doyle M, Yamrozik J, Lombardi R, Bonnet C, Mansour A and Biederman R (2021) Where do we go from here? Beyond the MagnaSafe trial: A focus beyond a 'safety-first' notion. An MRI study in 500 consecutive patients, International Journal of Cardiology, 10.1016/j.ijcard.2021.05.031, 336, (113-120), Online publication date: 1-Aug-2021. Dahiya G, Wetzel A, Kyvernitakis A, Gevenosky L, Williams R, Shah M, Farah V, Doyle M and Biederman R (2021) Impact of magnetic resonance imaging on functional integrity of non‐conditional cardiovascular implantable electronic devices, Pacing and Clinical Electrophysiology, 10.1111/pace.14298, 44:8, (1312-1319), Online publication date: 1-Aug-2021. Ryan J, Murray A, Gilligan P, Bisset J, Nolan C, Doyle A, Emerson B, Galvin J and Murray J (2020) MRI safety management in patients with cardiac implantable electronic devices: Utilizing failure mode and effects analysis for risk optimization, International Journal for Quality in Health Care, 10.1093/intqhc/mzaa067, 32:7, (431-437), Online publication date: 23-Sep-2020. Murray A, Gilligan P, Bisset J, Nolan C, Galvin J and Murray J (2018) Provision of MR imaging for patients with cardiac implantable electronic devices (CIEDs): a single-center experience and national survey, Irish Journal of Medical Science (1971 -), 10.1007/s11845-018-1922-y, 188:3, (999-1004), Online publication date: 1-Aug-2019. Shah A, Morris M, Hirsh D, Warnock M, Huang Y, Mollerus M, Merchant F, Patel A, Delurgio D, Patel A, Hoskins M, El Chami M, Leon A, Langberg J and Lloyd M (2018) Magnetic resonance imaging safety in nonconditional pacemaker and defibrillator recipients: A meta-analysis and systematic review, Heart Rhythm, 10.1016/j.hrthm.2018.02.019, 15:7, (1001-1008), Online publication date: 1-Jul-2018. Markman T, Halperin H and Nazarian S (2018) Update on MRI Safety in Patients with Cardiac Implantable Electronic Devices, Radiology, 10.1148/radiol.2018180360, 288:3, (656-657), Online publication date: 1-Sep-2018. Lupo P, Cappato R, Di Leo G, Secchi F, Papini G, Foresti S, Ali H, De Ambroggi G, Sorgente A, Epicoco G, Cannaò P and Sardanelli F (2018) An eight-year prospective controlled study about the safety and diagnostic value of cardiac and non-cardiac 1.5-T MRI in patients with a conventional pacemaker or a conventional implantable cardioverter defibrillator, European Radiology, 10.1007/s00330-017-5098-z, 28:6, (2406-2416), Online publication date: 1-Jun-2018. Samar H, Yamrozik J, Williams R, Doyle M, Shah M, Bonnet C and Biederman R (2017) Diagnostic Value of MRI in Patients With Implanted Pacemakers and Implantable Cardioverter-Defibrillators Across a Cross Population, JACC: Clinical Electrophysiology, 10.1016/j.jacep.2017.03.009, 3:9, (991-1002), Online publication date: 1-Sep-2017. Strom J, Whelan J, Shen C, Zheng S, Mortele K and Kramer D (2017) Safety and utility of magnetic resonance imaging in patients with cardiac implantable electronic devices, Heart Rhythm, 10.1016/j.hrthm.2017.03.039, 14:8, (1138-1144), Online publication date: 1-Aug-2017. SHAH A, PATEL A, KNEZEVIC A, HOSKINS M, HIRSH D, MERCHANT F, EL CHAMI M, DELURGIO D, PATEL A, LEON A, LANGBERG J and LLOYD M (2017) Clinical Performance of Magnetic Resonance Imaging Conditional and Nonconditional Cardiac Implantable Electronic Devices, Pacing and Clinical Electrophysiology, 10.1111/pace.13060, 40:5, (467-475), Online publication date: 1-May-2017. Nazarian S, Hansford R, Rahsepar A, Weltin V, McVeigh D, Gucuk Ipek E, Kwan A, Berger R, Calkins H, Lardo A, Kraut M, Kamel I, Zimmerman S and Halperin H (2017) Safety of Magnetic Resonance Imaging in Patients with Cardiac Devices, New England Journal of Medicine, 10.1056/NEJMoa1604267, 377:26, (2555-2564), Online publication date: 28-Dec-2017. Riley M and Epstein A (2017) Implantable Cardioverter-Defibrillator Programming and Troubleshooting Clinical Cardiac Pacing, Defibrillation and Resynchronization Therapy, 10.1016/B978-0-323-37804-8.00038-9, (1064-1089), . Carrillo R and Healy C (2015) Laser for Transvenous Lead Extraction Lasers in Cardiovascular Interventions, 10.1007/978-1-4471-5220-0_18, (245-253), . Taruya A, Tanaka A, Nishiguchi T, Iwaguro T, Ueno S, Okumoto Y, Kubo T, Akagi H and Akasaka T (2015) Necessity of magnetic resonance imaging examinations after permanent pacemaker implantation, International Journal of Cardiology, 10.1016/j.ijcard.2015.02.080, 184, (497-498), Online publication date: 1-Apr-2015. Awad K, Griffin J, Crawford T, Lane Cox S, Ferrick K, Mazur A, Pena R, Lloyd S, Michalski J, Johnson W and Bailey W (2015) Clinical safety of the Iforia implantable cardioverter-defibrillator system in patients subjected to thoracic spine and cardiac 1.5-T magnetic resonance imaging scanning conditions, Heart Rhythm, 10.1016/j.hrthm.2015.06.002, 12:10, (2155-2161), Online publication date: 1-Oct-2015. Tang Q, Guo L, Wang W, Zhou W, Liu Y, Liu H, Li L and Deng Y (2015) Usefulness of Contrast Perfusion Echocardiography for Differential Diagnosis of Cardiac Masses, Ultrasound in Medicine & Biology, 10.1016/j.ultrasmedbio.2015.05.010, 41:9, (2382-2390), Online publication date: 1-Sep-2015. Eitel C, Hindricks G, Grothoff M, Gutberlet M and Sommer P (2014) Catheter Ablation Guided by Real-Time MRI, Current Cardiology Reports, 10.1007/s11886-014-0511-6, 16:8, Online publication date: 1-Aug-2014. MESUBI O, AHMAD G, JEUDY J, JIMENEZ A, KUK R, SALIARIS A, SEE V, SHOROFSKY S and DICKFELD T (2014) Impact of ICD Artifact Burden on Late Gadolinium Enhancement Cardiac MR Imaging in Patients Undergoing Ventricular Tachycardia Ablation, Pacing and Clinical Electrophysiology, 10.1111/pace.12405, 37:10, (1274-1283), Online publication date: 1-Oct-2014. Verma A, Ha A, Dennie C, Essebag V, Exner D, Khan N, Lane C, Leipsic J, Philippon F, Sampaio M, Schieda N, Seifer C, Berthiaume A, Campbell D and Chakraborty S (2014) Canadian Heart Rhythm Society and Canadian Association of Radiologists Consensus Statement on Magnetic Resonance Imaging With Cardiac Implantable Electronic Devices, Canadian Journal of Cardiology, 10.1016/j.cjca.2014.07.010, 30:10, (1131-1141), Online publication date: 1-Oct-2014. Verma A, Ha A, Dennie C, Essebag V, Exner D, Khan N, Lane C, Leipsic J, Philippon F, Sampaio M, Schieda N, Seifer C, Berthiaume A, Campbell D and Chakraborty S (2014) Canadian Heart Rhythm Society and Canadian Association of Radiologists Consensus Statement on Magnetic Resonance Imaging with Cardiac Implantable Electronic Devices, Canadian Association of Radiologists Journal, 10.1016/j.carj.2014.08.001, 65:4, (290-300), Online publication date: 1-Nov-2014. Hussein A, Abutaleb A, Jeudy J, Phelan T, Patel R, Shkullaku M, Siddiqi F, See V, Saliaris A, Shorofsky S and Dickfeld T (2014) Safety of Computed Tomography in Patients With Cardiac Rhythm Management Devices, Journal of the American College of Cardiology, 10.1016/j.jacc.2013.12.040, 63:17, (1769-1775), Online publication date: 1-May-2014. Opel A and Segal O (2014) Cardiac pacing and implantable cardioverter defibrillators Oh's Intensive Care Manual, 10.1016/B978-0-7020-4762-6.00023-0, (260-270.e1), . Doppalapudi H, Blitzer M and Schoenfeld M (2014) Follow-Up of the Patient with a CIED Cardiac Pacing and ICDs, 10.1002/9781118459553.ch11, (453-503) Tamirisa P, Chen K and Jain G (2014) Primary Batteries for Medical Applications Encyclopedia of Applied Electrochemistry, 10.1007/978-1-4419-6996-5_382, (1713-1720), . Kanal E, Barkovich A, Bell C, Borgstede J, Bradley W, Froelich J, Gimbel J, Gosbee J, Kuhni-Kaminski E, Larson P, Lester J, Nyenhuis J, Schaefer D, Sebek E, Weinreb J, Wilkoff B, Woods T, Lucey L and Hernandez D (2013) ACR guidance document on MR safe practices: 2013, Journal of Magnetic Resonance Imaging, 10.1002/jmri.24011, 37:3, (501-530), Online publication date: 1-Mar-2013. Puckett C, Shapiro M and Goodlin S (2013) Congestive Heart Failure Geriatric Imaging, 10.1007/978-3-642-35579-0_11, (235-257), . Rod Gimbel J, Bello D, Schmitt M, Merkely B, Schwitter J, Hayes D, Sommer T, Schloss E, Chang Y, Willey S and Kanal E (2013) Randomized trial of pacemaker and lead system for safe scanning at 1.5 Tesla, Heart Rhythm, 10.1016/j.hrthm.2013.01.022, 10:5, (685-691), Online publication date: 1-May-2013. Takeuchi D and Tomizawa Y (2012) Pacing device therapy in infants and children: a review, Journal of Artificial Organs, 10.1007/s10047-012-0668-y, 16:1, (23-33), Online publication date: 1-Mar-2013. Arenal A, Hernandez J, Perez-David E, Rubio-Guivernau J, Ledesma-Carbayo M and Fernandez-Aviles F (2012) Do the spatial characteristics of myocardial scar tissue determine the risk of ventricular arrhythmias?, Cardiovascular Research, 10.1093/cvr/cvs113, 94:2, (324-332), Online publication date: 1-May-2012. Bilchick K (2012) Integration of CMR Scar Imaging and Electroanatomic Mapping, JACC: Cardiovascular Imaging, 10.1016/j.jcmg.2011.09.021, 5:2, (211-213), Online publication date: 1-Feb-2012. Cronin E and Wilkoff B (2012) Magnetic Resonance Imaging Conditional Pacemakers: Rationale, Development and Future Directions, Indian Pacing and Electrophysiology Journal, 10.1016/S0972-6292(16)30543-5, 12:5, (204-212), Online publication date: 1-Sep-2012. Boilson B, Wokhlu A, Acker N, Felmlee J, Watson R, Julsrud P, Friedman P, Cha Y, Rea R, Hayes D and Shen W (2011) Safety of magnetic resonance imaging in patients with permanent pacemakers: a collaborative clinical approach, Journal of Interventional Cardiac Electrophysiology, 10.1007/s10840-011-9615-8, 33:1, (59-67), Online publication date: 1-Jan-2012. Manaouil C, Fantoni S, Montpellier D, Tordjman E and Jarde O (2012) Patients implantés d'un stimulateur cardiaque : questions pratiques, La Presse Médicale, 10.1016/j.lpm.2011.09.025, 41:7-8, (736-744), Online publication date: 1-Jul-2012. Sra J, Anand R, Dickfeld T, Mehta A and Nanda N (2012) Essentials of Imaging and Imaging Technologies Related to Arrhythmias Electrophysiological Disorders of the Heart, 10.1016/B978-1-4377-0285-9.00017-X, (221-248), . Bilchick K, McVeigh E and Lardo A (2012) Dyssynchrony Evaluation: MRI and CCT Cardiac Imaging in Electrophysiology, 10.1007/978-1-84882-486-7_15, (233-250), . Dorenkamp M, Roser M, Hamm B and Haverkamp W (2012) Magnetresonanztomographie und implantierbare kardiale DevicesMagnetic resonance imaging and implantable cardiac devices, Herz, 10.1007/s00059-012-3588-y, 37:2, (136-145), Online publication date: 1-Mar-2012. Hsu C, Parker G and Puranik R (2012) Implantable Devices and Magnetic Resonance Imaging, Heart, Lung and Circulation, 10.1016/j.hlc.2012.04.004, 21:6-7, (358-363), Online publication date: 1-Jun-2012. Cronin E, Mahon N and Wilkoff B (2014) MRI in patients with cardiac implantable electronic devices, Expert Review of Medical Devices, 10.1586/erd.11.73, 9:2, (139-146), Online publication date: 1-Mar-2012. Tian J, Smith M, Ahmad G, Dilsizian V, Jimenez A and Dickfeld T (2012) Integration of 3-Dimensional Scar Models from SPECT to Guide Ventricular Tachycardia Ablation, Journal of Nuclear Medicine, 10.2967/jnumed.111.094904, 53:6, (894-901), Online publication date: 1-Jun-2012. Jung W, Zvereva V, Hajredini B and Jackle S (2012) Safe magnetic resonance image scanning of the pacemaker patient: current technologies and future directions, Europace, 10.1093/europace/eur391, 14:5, (631-637), Online publication date: 1-May-2012. Dickfeld T, Tian J, Ahmad G, Jimenez A, Turgeman A, Kuk R, Peters M, Saliaris A, Saba M, Shorofsky S and Jeudy J (2011) MRI-Guided Ventricular Tachycardia Ablation, Circulation: Arrhythmia and Electrophysiology, 4:2, (172-184), Online publication date: 1-Apr-2011. Sorrentino R (2011) A novel MRI-safe dual-chamber pacemaker system: Its time has come, Heart Rhythm, 10.1016/j.hrthm.2010.10.033, 8:1, (74-75), Online publication date: 1-Jan-2011. Zikria J, Machnicki S, Rhim E, Bhatti T and Graham R (2011) MRI of Patients With Cardiac Pacemakers: A Review of the Medical Literature, American Journal of Roentgenology, 10.2214/AJR.10.4239, 196:2, (390-401), Online publication date: 1-Feb-2011. Shinbane J, Colletti P and Shellock F (2011) Magnetic resonance imaging in patients with cardiac pacemakers: era of "MR Conditional" designs, Journal of Cardiovascular Magnetic Resonance, 10.1186/1532-429X-13-63, 13:1, Online publication date: 1-Dec-2011. Baikoussis N, Apostolakis E, Papakonstantinou N, Sarantitis I and Dougenis D (2011) Safety of Magnetic Resonance Imaging in Patients With Implanted Cardiac Prostheses and Metallic Cardiovascular Electronic Devices, The Annals of Thoracic Surgery, 10.1016/j.athoracsur.2011.02.068, 91:6, (2006-2011), Online publication date: 1-Jun-2011. Epstein A and Riley M (2011) Troubleshooting of Implantable Cardioverter-Defibrillators Clinical Cardiac Pacing, Defibrillation and Resynchronization Therapy, 10.1016/B978-1-4377-1616-0.00030-8, (889-910), . Tian J, Smith M and Dickfeld T (2011) Clinical Application of FDG-PET Imaging for Three-Dimensional Myocardial Scar and Left Ventricular Anatomy During Ventricular Tachycardia Ablation, PET Clinics, 10.1016/j.cpet.2011.08.005, 6:4, (393-402), Online publication date: 1-Oct-2011. Everitt M, Verma A and Saarel E (2011) The wearable external cardiac defibrillator for cancer patients at risk for sudden cardiac death, Community Oncology, 10.1016/S1548-5315(12)70086-4, 8:9, (400-403), Online publication date: 1-Sep-2011. Hasan R, Clifford S, Ghanbari H, Schmidt M, Segerson N and Daccarett M (2010) Imaging modalities in cardiac electrophysiology, Future Cardiology, 10.2217/fca.09.58, 6:1, (113-127), Online publication date: 1-Jan-2010. Kelle S and Nagel E (2010) Bildgebende Verfahren in der Ergometrie (MRT) Ergometrie, 10.1007/978-3-540-92730-3_10, (109-120), . Bottomley P, Kumar A, Edelstein W, Allen J and Karmarkar P (2010) Designing passive MRI-safe implantable conducting leads with electrodes, Medical Physics, 10.1118/1.3439590, 37:7Part1, (3828-3843), Online publication date: 29-Jun-2010. Dickfeld T (2010) Image-Guided Electrophysiology Mapping and Ablation Cardiac CT, PET and MR, 10.1002/9781444323894.ch14, (334-353) NAEHLE C, ZEIJLEMAKER V, THOMAS D, MEYER C, STRACH K, FIMMERS R, SCHILD H and SOMMER T (2009) Evaluation of Cumulative Effects of MR Imaging on Pacemaker Systems at 1.5 Tesla, Pacing and Clinical Electrophysiology, 10.1111/j.1540-8159.2009.02570.x, 32:12, (1526-1535), Online publication date: 1-Dec-2009. Ebinger M, De Silva D, Christensen S, Parsons M, Markus R, Donnan G and Davis S (2009) Imaging the penumbra – strategies to detect tissue at risk after ischemic stroke, Journal of Clinical Neuroscience, 10.1016/j.jocn.2008.04.002, 16:2, (178-187), Online publication date: 1-Feb-2009. Aliot E, Stevenson W, Almendral-Garrote J, Bogun F, Calkins C, Delacretaz E, Della Bella P, Hindricks G, Jaïs P, Josephson M, Kautzner J, Kay G, Kuck K, Lerman B, Marchlinski F, Reddy V, Schalij M, Schilling R, Soejima K and Wilber D (2009) EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias, Heart Rhythm, 10.1016/j.hrthm.2009.04.030, 6:6, (886-933), Online publication date: 1-Jun-2009. Kantor B, Nagel E, Schoenhagen P, Barkhausen J and Gerber T (2009) Coronary Computed Tomography and Magnetic Resonance Imaging, Current Problems in Cardiology, 10.1016/j.cpcardiol.2008.12.002, 34:4, (145-217), Online publication date: 1-Apr-2009. Roguin A (2009) Magnetic Resonance Imaging in Patients With Implantable Cardioverter-Defibrillators and Pacemakers, Journal of the American College of Cardiology, 10.1016/j.jacc.2009.04.047, 54:6, (556-557), Online publication date: 1-Aug-2009. Gore T, Rollings R and Gore A (2009) The Many Facets of Cardiovascular Magnetic Resonance Imaging: Review of Background, Clinical Utility, and Increasing Use in the Community Hospital, Southern Medical Journal, 10.1097/SMJ.0b013e3181a8e2c6, 102:7, (719-724), Online publication date: 1-Jul-2009. Tian J, Smith M, Jeudy J and Dickfeld T (2009) Multimodality Fusion Imaging Using Delayed-Enhanced Cardiac Magnetic Resonance Imaging, Computed Tomography, Positron Emission Tomography, and Real-Time Intracardiac Echocardiography to Guide Ventricular Tachycardia Ablation in Implantable Cardioverter-Defibrillator Patients, Heart Rhythm, 10.1016/j.hrthm.2009.02.032, 6:6, (825-828), Online publication date: 1-Jun-2009. TIAN J, SMITH M, CHINNADURAI P, DILSIZIAN V, TURGEMAN A, ABBO A, GAJERA K, XU C, PLOTNICK D, PETERS R, SABA M, SHOROFSKY S and DICKFELD T (2009) Clinical Application of PET/CT Fusion Imaging for Three-Dimensional Myocardial Scar and Left Ventricular Anatomy during Ventricular Tachycardia Ablation, Journal of Cardiovascular Electrophysiology, 10.1111/j.1540-8167.2008.01377.x, 20:6, (597-604), Online publication date: 1-Jun-2009. Aliot E, Stevenson W, Almendral-Garrote J, Bogun F, Calkins C, Delacretaz E, Bella P, Hindricks G, Jais P, Josephson M, Kautzner J, Kay G, Kuck K, Lerman B, Marchlinski F, Reddy V, Schalij M, Schilling R, Soejima K and Wilber D (2009) EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: Developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA), Europace, 10.1093/europace/eup098, 11:6, (771-817), Online publication date: 1-Jun-2009. Wilkoff B, Love C, Byrd C, Bongiorni M, Carrillo R, Crossley G, Epstein L, Friedman R, Kennergren C, Mitkowski P, Schaerf R and Wazni O (2009) Transvenous Lead Extraction: Heart Rhythm Society Expert Consensus on Facilities, Training, Indications, and Patient Management, Heart Rhythm, 10.1016/j.hrthm.2009.05.020, 6:7, (1085-1104), Online publication date: 1-Jul-2009. Nordbeck P, Fidler F, Weiss I, Warmuth M, Friedrich M, Ehses P, Geistert W, Ritter O, Jakob P, Ladd M, Quick H and Bauer W (2008) Spatial distribution of RF-induced E-fields and implant heating in MRI, Magnetic Resonance in Medicine, 10.1002/mrm.21475, 60:2, (312-319), Online publication date: 1-Aug-2008. Dickfeld T and Kocher C (2008) The role of integrated PET-CT scar maps for guiding ventricular tachycardia ablations, Current Cardiology Reports, 10.1007/s11886-008-0025-1, 10:2, (149-157), Online publication date: 1-Mar-2008. Klaunberg B and Davis J (2008) Considerations for Laboratory Animal Imaging Center Design and Setup, ILAR Journal, 10.1093/ilar.49.1.4, 49:1, (4-16), Online publication date: 1-Jan-2008. Sutton R, Kanal E, Wilkoff B, Bello D, Luechinger R, Jenniskens I, Hull M and Sommer T (2008) Safety of magnetic resonance imaging of patients with a new Medtronic EnRhythm MRI SureScan pacing system: clinical study design, Trials, 10.1186/1745-6215-9-68, 9:1, Online publication date: 1-Dec-2008. Dickfeld T, Lei P, Dilsizian V, Jeudy J, Dong J, Voudouris A, Peters R, Saba M, Shekhar R and Shorofsky S (2008) Integration of Three-Dimensional Scar Maps for Ventricular Tachycardia Ablation With Positron Emission Tomography-Computed Tomography, JACC: Cardiovascular Imaging, 10.1016/j.jcmg.2007.10.001, 1:1, (73-82), Online publication date: 1-Jan-2008. Delfino J, Fornwalt B, Oshinski J and Lerakis S (2008) Role of MRI in Patient Selection for CRT, Echocardiography, 10.1111/j.1540-8175.2008.00783.x, 25:10, (1176-1185) Naehle C, Meyer C, Thomas D, Remerie S, Krautmacher C, Litt H, Luechinger R, Fimmers R, Schild H and Sommer T (2008) Safety of Brain 3-T MR Imaging with Transmit-Receive Head Coil in Patients with Cardiac Pacemakers: Pilot Prospective Study with 51 Examinations, Radiology, 10.1148/radiol.2493072195, 249:3, (991-1001), Online publication date: 1-Dec-2008. Chiribiri A, Kelle S, Götze S, Kriatselis C, Thouet T, Tangcharoen T, Paetsch I, Schnackenburg B, Fleck E and Nagel E (2008) Visualization of the Cardiac Venous System Using Cardiac Magnetic Resonance, The American Journal of Cardiology, 10.1016/j.amjcard.2007.08.049, 101:3, (407-412), Online publication date: 1-Feb-2008. GIMBEL J (2008) Magnetic Resonance Imaging of Implantable Cardiac Rhythm Devices at 3.0 Tesla, Pacing and Clinical Electrophysiology, 10.1111/j.1540-8159.2008.01117.x, 31:7, (795-801), Online publication date: 1-Jul-2008. Planken R, Leiner T, Nijenhuis R, Duijm L, Cuypers P, Douwes-Draaijer P, Van Der Sande F, Kessels A and Tordoir J (2018) Contrast-Enhanced Magnetic Resonance Angiography Findings Prior to Hemodialysis Vascular access Creation: A Prospective Analysis, The Journal of Vascular Access, 10.1177/112972980800900408, 9:4, (269-277), Online publication date: 1-Oct-2008. Stevenson B, Dabney W and Frysz C (2007) Issues and Design Solutions Associated with Performing MRI Scans on Patients with Active Implantable Medical Devices 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 10.1109/IEMBS.2007.4353762, 978-1-4244-0787-3, (6166-6169) Nagel E, Bauer W, Sechtem U, Schulz-Menger J, Silber S, Voigtländer T, Moshage W, Kramer H, Ertl G and Fleck E (2007) Klinische Indikationen für die kardiovaskuläre Magnetresonanztomographie (CMR)Clinical indications for cardiovascular magnetic resonance imaging (CMR, Clinical Research in Cardiology Supplements, 10.1007/s11789-007-0049-x, 2:2, (77-96), Online publication date: 1-Apr-2007. Suzuki H, Sumiyoshi A, Kawashima R, Shimokawa H and Hoshi Y (2013) Different Brain Activation under Left and Right Ventricular Stimulation: An fMRI Study in Anesthetized Rats, PLoS ONE, 10.1371/journal.pone.0056990, 8:2, (e56990) Bertelsen L, Petersen H, Philbert B, Svendsen J, Thomsen C and Vejlstrup N (2016) Safety of magnetic resonance scanning without monitoring of patients with pacemakers, Europace, 10.1093/europace/euw066, (euw066) Bovenschulte H, Schlüter-Brust K, Liebig T, Erdmann E, Eysel P and Zobel C (2012) MRI in Patients With Pacemakers, Deutsches Ärzteblatt international, 10.3238/arztebl.2012.0270 September 19, 2006Vol 114, Issue 12 Advertisement Article InformationMetrics https://doi.org/10.1161/CIRCULATIONAHA.106.647800PMID: 16982951 Originally publishedSeptember 19, 2006 KeywordsEditorialsdefibrillationpacingimagingmagnetic resonance imagingpacemakersPDF download Advertisement SubjectsCatheter Ablation and Implantable Cardioverter-DefibrillatorComputerized Tomography (CT)Ethics and PolicyPacemaker
Referência(s)